BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28384)

  • 1. Adrenergic enzymes in cultured mouse neuroblastoma: absence of detectable aromatic-L-amino-acid decarboxylase.
    Waymire JC; Gilmer-Waymire K
    J Neurochem; 1978 Sep; 31(3):693-8. PubMed ID: 28384
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcellular distribution of catecholamines and enzymes in human neuroblastoma.
    De Potter WP; De Schaepdryver AF; De Smet F; Delbeke MJ; Hooft C
    Experientia; 1974 Nov; 30(11):1323-4. PubMed ID: 4154867
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of ethanol and malnutrition on the development of catecholamine neurons: changes in specific activities of enzymes.
    Detering N; Edwards E; Ozand P; Karahasan A
    J Neurochem; 1980 Feb; 34(2):297-304. PubMed ID: 6106048
    [No Abstract]   [Full Text] [Related]  

  • 4. Axonal transport of catecholamine synthesizing and metabolizing enzymes.
    Wooten GF; Coyle JT
    J Neurochem; 1973 May; 20(5):1361-71. PubMed ID: 4123797
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular geometry and adrenergic drug activity.
    Patil PN; Miller DD; Trendelenburg U
    Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
    [No Abstract]   [Full Text] [Related]  

  • 6. Catecholamine contents and activities of catecholamine synthesizing and inactivating enzymes in the salivary glands of young growing rats.
    Kuzuya H; Ikeno T; Ikeno K; Nemoto K; Hashimoto S
    Arch Oral Biol; 1980; 25(1):31-6. PubMed ID: 6105862
    [No Abstract]   [Full Text] [Related]  

  • 7. Tyrosine hydroxylase in human adrenal glands and human pheochromocytoma.
    Nagatsu T; Mizutani K; Sudo Y; Nagatsu I
    Clin Chim Acta; 1972 Jul; 39(2):417-24. PubMed ID: 4402930
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of catecholamine turnover by variations of enzyme levels.
    Pletscher A
    Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
    [No Abstract]   [Full Text] [Related]  

  • 9. Central neurotransmitters and aging.
    Pradhan SN
    Life Sci; 1980 May; 26(20):1643-56. PubMed ID: 6104765
    [No Abstract]   [Full Text] [Related]  

  • 10. [The monoamines in molluscs. I. Catecholamines: biosynthesis, disposition and inactivation (author's transl)].
    Cardot J
    J Physiol (Paris); 1979; 75(7):689-713. PubMed ID: 44729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
    Szmigielska H
    Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism and pathology of catecholamines].
    Traba ML
    Rev Clin Esp; 1981 Jul 15-31; 162(1-2):5-13. PubMed ID: 6117933
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.
    Vieira-Coelho MA; SerrĂ£o MP; Afonso J; Pinto CE; Moura E
    Br J Pharmacol; 2009 Oct; 158(3):726-37. PubMed ID: 19703163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse neuroblastoma clone N1E-115: a suitable model for studying the action of dopamine agonists of tyrosine hydroxylase activity.
    Bräutigam M; Dreesen R; Flosbach CW; Herken H
    Biochem Pharmacol; 1982 Apr; 31(7):1279-82. PubMed ID: 6124255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of noradrenaline in the sympathetic neurone.
    Axelrod J
    Harvey Lect; 1973; 67():175-97. PubMed ID: 4145715
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of neurotransmitter release in the pathogenesis of hypertension.
    Louis WJ; Jarrott B; Burnstock G; Watanabe H
    Contrib Nephrol; 1977; 8():182-9. PubMed ID: 19200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymes related to monoamine transmitter metabolism in brain microvessels.
    Hardebo JE; Emson PC; Falck B; Owman C; Rosengren E
    J Neurochem; 1980 Dec; 35(6):1388-93. PubMed ID: 6108352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of trimipramine, an atypical tricyclic antidepressant, on the activities of various enzymes involved in the metabolism of biogenic amines.
    Yu PH; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):409-16. PubMed ID: 1972801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.